MORGAN STANLEY - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 26 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$396
-2.5%
4,4160.0%0.00%
Q2 2023$406
+488.4%
4,416
+1560.2%
0.00%
Q1 2023$69
+9.5%
266
-10.4%
0.00%
Q4 2022$63297
+11.7%
0.00%
Q3 2022$02660.0%0.00%
Q2 2022$0266
-48.8%
0.00%
Q1 2022$0520
+64.0%
0.00%
Q4 2021$0
-100.0%
317
-88.7%
0.00%
Q3 2021$5,000
-76.2%
2,816
-75.3%
0.00%
Q2 2021$21,000
-44.7%
11,383
-39.7%
0.00%
Q1 2021$38,000
+72.7%
18,883
+84.2%
0.00%
Q4 2020$22,000
+4.8%
10,250
+32.3%
0.00%
Q3 2020$21,000
-32.3%
7,7500.0%0.00%
Q2 2020$31,000
+416.7%
7,7500.0%0.00%
Q1 2020$6,000
-40.0%
7,750
-1.3%
0.00%
Q4 2019$10,000
+100.0%
7,8500.0%0.00%
Q3 2019$5,0000.0%7,8500.0%0.00%
Q2 2019$5,0007,8500.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q1 2022
NameSharesValueWeighting ↓
Allred Capital Management, LLC 36,838$26,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 102,440$74,0000.00%
PDS Planning, Inc 10,565$8,0000.00%
UBS Group AG 105$00.00%
Parallel Advisors, LLC 350$00.00%
BANK OF AMERICA CORP /DE/ 1,722$1,0000.00%
WELLS FARGO & COMPANY/MN 4,954$3,0000.00%
NORTHERN TRUST CORP 39,414$28,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 227,452$164,0000.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders